Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 1st. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of […]
Van ECK Associates Corp trimmed its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 14.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,942,442 shares of the company’s stock after selling 323,647 shares during […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock investors purchased 33,848 call options on the company. This is an increase of 52% compared to the typical volume of 22,258 call options. Insider Buying and Selling at Teva Pharmaceutical Industries In other news, CAO […]
Duality Advisers LP purchased a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 155,267 shares of the company’s stock, valued at approximately $1,621,000. Other institutional investors also recently bought and […]
Tobam lowered its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 6.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 362,069 shares of the company’s stock after selling 23,827 shares during the quarter. Tobam’s holdings in Teva Pharmaceutical Industries were worth $3,780,000 at the end of the most recent […]